Dan Gustafson Testifies Before House Subcommittee

WASHINGTON D.C. - Dan Gustafson, who is heading an American Antitrust Institute Pharmacy Benefit Manager Merger Ad Hoc Working Group, testified before the House Judiciary Subcommittee on Intellectual Property, Competition and Internet at the hearing on “The Proposed Merger between Express Scripts and Medco” in his individual capacity as an antitrust practitioner, raising concerns regarding the possible anti-competitive effects of a merger between two of the three largest pharmacy benefit managers.PBM Merger Testimony of Dan GustafsonPBM Merger Hearing Transcript of Dan GustafsonPBM Merger Hearing TranscriptPBM Merger American Antitrust Article